Table 2.
Clinicopathological characteristics of RCC patients with differential Rad54l2 expression.
| Characteristic | Low expression of RAD54L2 | High expression of RAD54L2 | p |
|---|---|---|---|
| n | 265 | 265 | |
| Gender, n (%) | 0.005 | ||
| Female | 77 (14.5%) | 109 (20.6%) | |
| Male | 188 (35.5%) | 156 (29.4%) | |
| Age, n (%) | 0.019 | ||
| ≤ 60 | 118 (22.3%) | 146 (27.5%) | |
| > 60 | 147 (27.7%) | 119 (22.5%) | |
| T stage, n (%) | 0.020 | ||
| T1 | 118 (22.3%) | 153 (28.9%) | |
| T2 | 39 (7.4%) | 30 (5.7%) | |
| T3 | 103 (19.4%) | 76 (14.3%) | |
| T4 | 5 (0.9%) | 6 (1.1%) | |
| N stage, n (%) | 1.000 | ||
| N0 | 115 (45.1%) | 124 (48.6%) | |
| N1 | 8 (3.1%) | 8 (3.1%) | |
| M stage, n (%) | 0.711 | ||
| M0 | 208 (41.8%) | 212 (42.6%) | |
| M1 | 41 (8.2%) | 37 (7.4%) | |
| Pathologic stage, n (%) | 0.011 | ||
| Stage I | 115 (21.8%) | 150 (28.5%) | |
| Stage II | 30 (5.7%) | 27 (5.1%) | |
| Stage III | 75 (14.2%) | 48 (9.1%) | |
| Stage IV | 44 (8.3%) | 38 (7.2%) | |
| Histologic grade, n (%) | 0.004 | ||
| G1 | 2 (0.4%) | 12 (2.3%) | |
| G2 | 103 (19.7%) | 124 (23.8%) | |
| G3 | 113 (21.6%) | 93 (17.8%) | |
| G4 | 44 (8.4%) | 31 (5.9%) |
RCC renal cell carcinoma.